AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$206.68
−0.80%Margins
Gross margin
93.2%
EBITDA margin
-23.2%
EBIT margin
-24.3%
Net margin
-24.7%
FCF margin
-9.2%
-230.1%
Return on equity
-25.2%
Return on assets
-62.3%
Return on invested capital
1.05x
Asset turnover
-$71.3M
Cash from operations
$6.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026